For example, the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) gene has been identified as a key player for microglia function in AD pathology [32,33,34], where TREM2 loss of function is associated with increased amyloid burden [35] and exacerbated neuronal loss [36]. This evidence concerns the gene TREM2 and Alzheimer disease.